Digital Diabetes Management Market Report 2026

The digital diabetes management market size has grown exponentially in recent years. It will grow from $19.19 billion in 2025 to $23.99 billion in 2026 at a compound annual growth rate (CAGR) of 25%. The growth in the historic period can be attributed to rising global diabetes burden, limited access to continuous clinical care, growth of smartphone usage, increasing demand for self-management tools, expansion of digital health solutions.

The digital diabetes management market size is expected to see exponential growth in the next few years. It will grow to $58.13 billion in 2030 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to increasing ai adoption in diabetes care, expansion of remote patient monitoring, rising telehealth acceptance, integration with electronic health records, demand for personalized diabetes management. Major trends in the forecast period include rapid adoption of remote diabetes monitoring platforms, integration of AI-based glucose analytics, expansion of mobile diabetes management applications, increasing use of wearable diabetes devices, growth of telemedicine-based diabetes care.

The rising prevalence of diabetes is expected to drive the growth of the digital diabetes management market in the coming years. Diabetes is a metabolic disorder characterized by elevated blood glucose levels, most commonly type 2 diabetes, which affects the body’s ability to produce or effectively use insulin. The prevalence of diabetes is increasing largely due to growing obesity rates, which significantly contribute to insulin resistance and raise the risk of developing type 2 diabetes. As diabetes cases continue to rise, demand for digital diabetes management solutions is growing, with healthcare providers and patients increasingly adopting remote monitoring tools, app-based tracking, and personalized digital coaching to manage the condition more effectively. For instance, in June 2024, according to NHS England, a UK-based government agency, the number of individuals under the age of 40 at risk of type 2 diabetes increased by nearly 25%, rising from 173,166 in 2022 to 216,440 in 2023. Therefore, the increasing prevalence of diabetes is driving demand for the digital diabetes management market.

Major companies operating in the digital diabetes management market are concentrating on developing advanced technologies such as long-term implantable continuous glucose monitoring (CGM) systems to reduce patient burden, enable continuous real-time glucose tracking, and improve overall diabetes management. Long-term implantable CGM systems are devices placed under the skin that continuously monitor glucose levels over extended periods, delivering consistent data without the need for frequent sensor replacements associated with traditional short-term CGMs. For instance, in September 2024, Senseonics Holdings Inc., a US-based medical technology company, received FDA clearance for Eversense 365, the world’s first fully implantable CGM system with a 365-day lifespan. Designed for adults with type 1 and type 2 diabetes, the system transmits glucose readings every five minutes to a mobile application, requires weekly calibration after the initial two-week period, and features a removable transmitter. This long-duration solution minimizes lifestyle disruption, reduces sensor replacement frequency, and supports integration with automated insulin delivery systems, offering a more seamless and accurate digital diabetes management experience.

In May 2023, Medtronic PLC, an Ireland-based medical technology company, acquired EOFLOW Co., Ltd. for $738 million. Through this acquisition, Medtronic aims to advance automated diabetes management by developing an integrated closed-loop system that combines tubeless insulin delivery devices with continuous glucose monitoring and meal-detection algorithms. EOFLOW Co., Ltd. is a South Korea-based company specializing in digital and smart wearable solutions for diabetes management.

Major companies operating in the digital diabetes management market are Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.

North America was the largest region in the digital diabetes management market in 2025. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital diabetes management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the digital diabetes management market by increasing costs of imported wearable sensors, connected devices, and cloud-enabled monitoring hardware. Healthcare providers in North America and Europe are most affected due to dependence on imported digital health devices, while Asia-Pacific faces higher costs for connected infrastructure. These tariffs increase platform deployment costs. However, they are also accelerating local device production, regional software development, and stronger digital healthcare ecosystems.

The digital diabetes management market research report is one of a series of new reports that provides digital diabetes management market statistics, including digital diabetes management industry global market size, regional shares, competitors with a digital diabetes management market share, detailed digital diabetes management market segments, market trends and opportunities, and any further data you may need to thrive in the digital diabetes management industry. This digital diabetes management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital diabetes management involves the use of electronic medical solutions to remotely monitor, analyze, and manage diabetes. These tools enable individuals with diabetes, or those at risk of developing the condition, to better manage their health independently and improve overall health outcomes through continuous tracking and data-driven insights.

The main product and service categories in digital diabetes management include devices, applications, data management software and platforms, and services. A data management platform (DMP) is software designed to collect, store, and manage data, allowing organizations to organize information and apply it effectively across digital systems. The key device types include handheld devices and wearable devices, which are used across settings such as self or home healthcare, hospitals, specialty diabetes clinics, and others.

The digital diabetes management market consists of revenue generated by the companies offering devices and services that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patients' blood glucose levels and controlling their conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.